Blood urea nitrogen and clinical prognosis in patients with COVID-19: A retrospective study.

Publication date: Feb 23, 2024

The aim of this study was to estimate the association between blood urea nitrogen (BUN) and clinical prognosis in patients with COVID-19. A multicenter, retrospective study was conducted in adult patients with COVID-19 in 3 hospitals in Zhenjiang from January 2023 to May 2023. Patients were divided into survival and death group based on whether they survived at day 28. The demographic, comorbidities, and laboratory data were independently collected and analyzed, as well as clinical outcomes. Total 141 patients were enrolled and 23 (16. 3%) died within 28 days. Patients who died within 28 days had a higher level of BUN compared with survivors. Bivariate logistic regression analysis showed that BUN was a risk factor for 28-day mortality in patients with COVID-19. ROC curve showed that BUN could predict 28-day mortality of COVID-19 patients (AUC = 0. 796, 95%CI: 0. 654-0. 938, P 

Concepts Keywords
Hospitals Aim
January Blood
Laboratory Bun
Mortality Clinical
Covid
Day
Days
Died
Mortality
Nitrogen
Prognosis
Retrospective
Showed
Study
Urea

Semantics

Type Source Name
disease IDO blood
drug DRUGBANK Urea
drug DRUGBANK Nitrogen
disease MESH COVID-19
disease MESH death
drug DRUGBANK Saquinavir

Original Article

(Visited 1 times, 1 visits today)